Interlaboratory evaluation of a multiplexed high information content in vitro genotoxicity assay
Steven M. Bryce(Litron Laboratories (United States)), Stephen D. Dertinger(Litron Laboratories (United States)), Maria Engel(Pfizer (United States)), Elisabeth Lorge(Servier (France)), Sabrina Wilde(Bayer (Germany)), Melanie Guérard(Roche (Switzerland)), Richard A. Spellman(Pfizer (United States)), Derek T. Bernacki(Litron Laboratories (United States)), Andreas Zeller(Roche (Switzerland)), Pekka T. Heikkinen(Orion Corporation (Finland)), Nina Queisser(Heinrich Heine University Düsseldorf), Andreas Sutter(Bayer (Germany)), David Kirkland(Covance (United Kingdom)), Maik Schuler(Pfizer (United States)), Jeffrey C. Bemis(Litron Laboratories (United States)), Véronique Thybaud(Sanofi (France)), Ulrike Hemmann(Sanofi (Germany))
Cited by 74
Related Papers
How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2007|437
The in vivo Pig-a assay: A report of the International Workshop On Genotoxicity Testing (IWGT) Workgroup
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2014|156
Strategy for genotoxicity testing: Hazard identification and risk assessment in relation to in vitro testing
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2006|131
Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells
|Mutation Research Letters|1995|119
Improvement of in vivo genotoxicity assessment: Combination of acute tests and integration into standard toxicity testing
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2010|106